About Us
Nanophysics & Beyond
Curadigm
The Management
Our Commitments
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Shareholders
Corporate Presentation
Financial Calendar
Regulated Information
Annual General Meetings
Shareholder Corner
Press Releases
Nanotalks
NBTXR3 Development
Head & Neck Cancer
R&D Day
Congresses
& Events
Our Expert Videos
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Financial | Revenue for the 1st quarter of 2016
Financial | Nanobiotix 2015 Annual Results
29 April 2016
Scientific Clinical | Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology
31 May 2016
Financial | Revenue for the 1st quarter of 2016
Published by
adminvl
on
13 May 2016
No translations available for this page
